FDA Approves New OTC Naloxone Nasal Spray For Opioid Overdose
June 17, 2026
June 17, 2026
JEFFERSON CITY, Missouri, June 17 [Category: Health Care] -- The Missouri Hospital Association posted the following news:
* * *
FDA Approves New OTC Naloxone Nasal Spray For Opioid Overdose
*
The U.S. Food and Drug Administration approved Rextovy, a new over-the-counter intranasal naloxone spray (4 mg dose), making it the third nonprescription option available in the U.S. for reversing opioid overdoses.
Naloxone is the standard tr . . .
* * *
FDA Approves New OTC Naloxone Nasal Spray For Opioid Overdose
*
The U.S. Food and Drug Administration approved Rextovy, a new over-the-counter intranasal naloxone spray (4 mg dose), making it the third nonprescription option available in the U.S. for reversing opioid overdoses.
Naloxone is the standard tr . . .